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Department Nociception and Pain, 21 rue René Descartes, F-67084 Strasbourg Cedex, Strasbourg, France
Received 2 April 2008; received in revised form 10 June 2008; accepted 10 June 2008Abstract
Fast Inhibitory controls mediated by glycine (GlyRs) and GABAA receptors (GABAARs) play an important role to prevent the
apparition of pathological pain symptoms of allodynia and hyperalgesia. The use of positive allosteric modulators of these receptors,
specifically expressed in the spinal cord, may represent an interesting strategy to limit or block pain expression. In this study, we have
used stereoisomers of progesterone metabolites, acting only via non-genomic effects, in order to evaluate the contribution of GlyRs
and GABAARs for the reduction of mechanical and thermal heat hypernociception. We show that 3a neurosteroids were particularly
efficient to elevate nociceptive thresholds in naive animal. It also reduced mechanical allodynia and thermal heat hyperalgesia in the
carrageenan model of inflammatory pain. This effect is likely to be mediated by GABAA receptors since 3b isomer was inefficient.
More interestingly, 3a5b neurosteroid was only efficient on mechanical allodynia while having no effect on thermal heat hyperalgesia.
We characterized these paradoxical effects of 3a5b neurosteroid using the strychnine and bicuculline models of allodynia. We clearly
show that 3a5b neurosteroid exerts an antinociceptive effect via a positive allosteric modulation of GABAARs but, at the same time,
is pronociceptive by reducing GlyR function. This illustrates the importance of the inhibitory amino acid receptor channels and their
allosteric modulators in spinal pain processing. Moreover, our results indicate that neurosteroids, which are synthesized in the dorsal
horn of the spinal cord and have limited side effects, may be of significant interest in order to treat pathological pain symptoms.
 2008 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
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Neuroactive steroids might be of significant interest to
treat severe neuropathologies [10,11,30] associated with
neuronal hyperexcitability. Non-genomic rapid effects
of neurosteroids are particularly efficient while using
allopregnanolone (3a5aTHP: 3a,5a-tetrahydro-proges-
terone) or pregnanolone (3a5bTHP: 3a,5b-tetrahydro-
progesterone), two metabolites of progesterone which
acts at nanomolar concentration on GABAA receptors0304-3959/$34.00  2008 International Association for the Study of Pain. P
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the central nervous system [16,35]. Interestingly, changes
in the level of endogenous 3a-neurosteroids have been
reported in many physiological [3,21,24,26] and patho-
logical situations [2,7,8,11,12,30,35]. Recently, the neu-
rosteroid binding sites on GABAARs have been
identified and characterized [17]. Depending on the sub-
unit composition of GABAARs [16], a positive allosteric
modulation is achieved by 3a-neurosteroids binding in a
cavity within in the transmembrane domains of the a
subunit, whereas a direct activation of the receptor is
possible if the neurosteroids bind to interfacial residues
between a and b subunits. This indicates that neuroster-
oids preferentially access the receptor from theublished by Elsevier B.V. All rights reserved.
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membrane diffusion [1]. Apart from GABAARs, other
receptor-channels were shown to be modulated by exog-
enously-applied steroids [33], mostly used at high con-
centrations (>10 lM). Among them, however, a recent
study indicated that pregnanolone significantly reduced
glycine receptor (GlyR) function [19]. The reduction of
glycinergic current was seen at micromolar concentra-
tions and was more pronounced if the channels were
composed of the a3 subunit which is strongly expressed
in the spinal nociceptive system [15]. The level of spinal
inhibition is a key element to prevent the apparition of
pathological pain symptoms [5,6,15]. This is well illus-
trated by intrathecal injection of the GABAAR antago-
nist or the GlyR antagonist, which both trigger the
apparition of a short-lasting allodynia [18,37]. Recently,
we have demonstrated that the elevated concentration of
neurosteroids seen in inflammatory pain states signifi-
cantly reduced thermal heat hyperalgesia [32].
The aim of this work was to characterize the rapid
(receptor-channel mediated) effects of different reduced
metabolites of progesterone (3a5aTHP, 3a5bTHP, and
3b5bTHP) on nociceptive thresholds and pathological
pain symptoms. We focused our attention on their possible
spinal action since some of them are synthesized locally
[21,27,32,35] and others, from peripheral origin [4,25,26],
likely reach the spinal cord after crossing the blood brain
barrier. More precisely, we have analyzed the action of
the three stereoisomers on mechanical and thermal heat
nociception. This led us to dissect the relative antinocicep-
tive contribution of 5aTHP and 5bTHP based on their
allosteric modulation of GABAARs and/or GlyRs.
2. Methods
2.1. Animals
Male Sprague–Dawley rats (300–450 g; Janvier, Le
Genest St. Isle, France) were used for this study. They
were housed by a group of four under standard condi-
tions (room temperature, 22 C; 12/12 h light/dark
cycle) with ad libitum access to food and water. All ani-
mals were manipulated and habituated to the tests and
to the room for at least 1 week. All behavioral tests were
done during the light period (i.e., between 7:00 and
19:00). All the procedures were performed in accordance
with European committee council Direction of Novem-
ber 24, 1986 (86/609/EEC), authorization from French
Department of Agriculture (license number 67-116 to
PP) and from the regional ethic committee.
2.2. Behavioral testing
2.2.1. Mechanical allodynia
In all the experimentations, to test the animal
mechanical sensitivity, we used a calibrated forceps(Bioseb, Chaville, France) previously developed in our
laboratory [23]. Briefly, the habituated rat is loosely
restrained with a towel masking the eyes in order to limit
stress by environmental stimulations. The tips of the for-
ceps are placed at each side of the paw and a graduate
force is applied. The pressure producing a withdrawal
of the paw, or in some rare cases a vocalization of the
animal, corresponded to the nociceptive threshold value.
This manipulation was performed three times for each
hindpaw and the values were averaged.
2.2.2. Thermal allodynia/hyperalgesia
To test the animal heat sensitivity, two different tests
were used. We used the Plantar test with Hargreaves
method (Ugo Basile, Comerio, Italy) to compared the
response of each hindpaw [14] when we tested healthy
animals and animals having received unilateral intrapl-
antar carrageenan injection. Exposed to a radiant heat,
the latency time of paw withdrawal was measured. Hot
plate (Bioseb, Chaville, France) set at a fixed tempera-
ture of 52 C allowed us to measure the paw withdrawal
latency of rats quickly after the induction of a transient
allodynia resulting from the intrathecal injection of
bicuculline or strychnine.
2.2.3. Drugs
Neurosteroids were injected at 1 lM and 10 lM, at
concentrations compatible with their known allosteric
modulation of glycine and GABAA receptor channel-
function. Two stock solutions of pregnanolone
(5b-pregnan-3a-ol-20-one), allopregnanolone (5a-preg-
nan-3a-ol-20-one), and epipregnanolone (5b-pregnan-
3b-ol-20-one) were prepared in ethanol 96% at
concentrations of 1 mM and 10 mM, respectively. The
day of the experiment, stock solution were diluted a
thousand times in NaCl 0.9% to obtain the injectable
solution. The final solution of ethanol was ineffective to
change the nociceptive thresholds as well as the pain
symptoms. Moreover, it allowed a rapid increase in the
spinal concentration of neurosteroid, a prerequisite to
study the fast allosteric modulation of spinal receptor-
channels. All drugs or vehicle were administered intra-
thecally (i.t.) on animals lightly anaesthetized with halo-
thane 3%. Acute intrathecal injection was realized by
puncture through the intervertebral space between L5
and L6 using a 50-micromolar Hamilton microsyringe
with a 26-gauge needle. A characteristic tail flick indi-
cated penetration of the needle in the intrathecal space
and ensures success for the delivery of the drug. After
injection of either 10 lL (majority of experiments) or
20 lL (strychnine and bicuculline experiments) of the
drug solution or vehicle, the animal was immediately
recovered from halothane anesthesia and was placed in
the testing chamber. In order to estimate the possible
spinal effect of the neurosteroids, rats were tested for
mechanical thermal nociception immediately after the
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recovery. In the case of strychnine- or bicuculline-
induced allodynia, animals were tested at the post-injec-
tion time of 15 min and 30 min, respectively, due to the
short-lasting effect of these compounds.
2.2.4. Carrageenan model of inflammatory pain
In order to induce a peripheral inflammation, 150 ll
of k-carrageenan (Sigma, St. Louis, MO), prepared at
3% in NaCl 0.9%, was injected in the right hindpaw of
the rat. All carrageenan injections were performed under
light halothane anesthesia (3%). Animals were used 24 h
after the paw injection, a period during which animals
exhibited a clear mechanical allodynia and thermal heat
hyperalgesia.
2.2.5. Strychnine- and bicuculline-induced allodynia
Strychnine or bicuculline were used to block spinal
glycine and GABAA receptors, a procedure which pro-
duces a transient mechanical and thermal allodynia
[18,37]. In our experiment, rats were intrathecally
injected with 20 ll of NaCl 0.9 % containing 20 lg of
strychnine or 1 lg of bicuculline. We tested mechanical
and thermal sensitivities 15 min or 30 min after i.t. injec-
tion of strychnine or bicuculline, respectively.
2.2.6. Statistical analysis
Data are expressed as mean ± standard error of the
mean (SEM). Statistical tests were performed with Stat-
istica 5.1 (Statsoft, Tulsa, Oklahoma, USA) using
repeated-measures two-way ANOVA, with the follow-
ing factors: treatment (between), and time (within).
When the ANOVA test was significant, the Tukey test
was used for post-hoc multiple comparisons between
individual groups. Results were considered to be statis-
tically significant if p values were below 0.05 (), 0.01
(), and 0.001 ().
3. Results
3.1. Antinociceptive action of neurosteroids in healthy rats
In this study, we aimed at evaluating the efficacy of
spinal neurosteroids, described as allosteric modulators
of inhibitory amino acid receptor-channels (i.e. GlyRs,
GABAARs), to control mechanical and thermal noci-
ception. We first measured the nociceptive thresholds
to heat and to a mechanical stimuli in healthy rats hav-
ing received an intrathecal injection of pregnanolone
(3a5bTHP) or allopregnanolone (3a5aTHP), two neu-
rosteroids which have an equal efficacy to potentiate
GABAAR function at low micromolar concentrations.
Epipregnanolone (3b5bTHP) has no described effect
on these receptor-channels and was used to evaluate
possible non-specific effect resulting from changes in
the membrane properties. Thresholds were measured1, 4, and 24 h after the initial injection and compared
to the control, i.e. threshold measured before the
injection.
3a5aTHP and 3a5bTHP (both at 1 and 10 lM) sig-
nificantly and dose-dependently increased the mechani-
cal thresholds whereas 3b5bTHP (10 lM) and vehicle
were ineffective (Fig. 1, panels A1 and A2). Four hours
after i.t. injection, 3a5aTHP and 3a5bTHP had a simi-
lar antinociceptive potency which ranged from
4.88 ± 0.51% to 12.09 ± 0.84% using 1 and 10 lM of
each, respectively (n = 6 per group and concentration;
ANOVA, p < 0.001). For example, in the case of
3a5aTHP (10 lM), the mean threshold was increased
from a value of 410.96 ± 2.41 g to a maximum value
of 460.10 ± 2.02 g at 4 h (n = 6, ANOVA, p < 0.001).
Twenty-four hours after i.t. injection, thresholds were
back to the control values (407.60 ± 1.36 g; n = 6). A
similar observation was made for all neurosteroids
tested indicating that these compounds were no more
efficient to modulate nociceptive thresholds 24 h after
i.t. injection.
A slightly different situation was observed while test-
ing the animals with thermal heat stimulus. At both con-
centrations (1 and 10 lM), 3a5aTHP increased the
hindpaw latency time thus confirming its antinociceptive
action for thermal heat (Fig. 1, panels B1 and B2). The
lowest concentration of 3a5aTHP (1 lM) strongly
increased the withdrawal latency from 7.17 ± 0.41 s to
8.87 ± 0.36 s at 4 h (n = 6; ANOVA, p < 0.001). This
corresponded to a 32.48 ± 6.36% change in latency time.
Interestingly, used at 10 lM, 3a5aTHP had a lower effi-
cacy (14.90 ± 5.06% change, n = 6; ANOVA, p > 0.05)
but still had a significant antinociceptive effect at 4 h.
With this thermal heat modality, we failed to reveal
any antinociceptive effect after injection of 3a5bTHP,
3b5bTHP or of the vehicle (Fig. 1, panel B2). Similarly
to what observed with the mechanical modality, all val-
ues were back to control after 24 h.
3.2. Antinociceptive action of neurosteroids in
carrageenan-treated rats
In order to evaluate the antinociceptive role of neu-
rosteroids in a pathophysiological pain situation, we
used the k-carrageenan model of inflammatory pain to
measure nociceptive thresholds in animals before and
after being intrathecally injected with neurosteroids
(Fig. 2). As expected, 24 h after the injection of k-carra-
geenan in the animal hindpaw, we found very low noci-
ceptive threshold values for mechanical (carrageenan:
227.98 ± 12.92 g vs. control: 418.67 ± 2.92 g, n = 36;
ANOVA, p < 0.001) and thermal modalities (carra-
geenan: 5.69 ± 0.74 s vs. control: 9.35 ± 1.49 s, n = 36;
ANOVA, p < 0.001).
Mechanical allodynia was efficiently reduced using
3a5aTHP or 3a5bTHP, injected at 1 lM and 10 lM
Fig. 1. Effects of progesterone metabolites 3a5aTHP, 3a5bTHP, and 3b5bTHP on mechanical and thermal heat nociceptive thresholds exhibited by
naive animals. Top graphs show the time course of the change in pressure threshold (A1) and latency time (B1) after the intrathecal injection of
3a5aTHP (1 lM and 10 lM). The histograms below (A2, B2) summarize the changes observed in pressure thresholds (A2) and latency times (B2) 4 h
after the intrathecal injections of 3a5aTHP, 3a5bTHP, and 3b5bTHP. ND, Not determined. Asterisk indicates statistical significance (***p < 0.001;
**p < 0.01; *p < 0.05, n = 6 per group) using ANOVA (A1 and B1, compared to pretest; A2 and B2 compared to vehicle).
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3a5aTHP was already maximal (42.83 ± 13.67%; from
200.56 ± 21.85 g to 275.06 ± 17.32 g 4 h after i.t. injec-
tion, n = 6; ANOVA, p < 0.001) using the lower concen-
tration of 1 lM. This was not the case for 3a5bTHP
which produced a dose-dependent effect, ranging from
24.58 ± 5.15% to 40.28 ± 5.94% using 1 or 10 lM,
respectively. Injection of the vehicle had no effect.
Similarly to what was observed in naive animals,
3a5aTHP reduced thermal heat hyperalgesia whereas
3a5bTHP and vehicle had no effect (Fig. 2B). Moreover,
the increase in paw latency following injection of
3a5aTHP was maximal using 1 lM (at 4 h 65.6 ±
10.44% increase from 3.91 ± 0.36 s to 6.53 ± 0.83 s in
3a5aTHP, n = 6; ANOVA, p < 0.001). Using a higher
concentration (10 lM), 3a5aTHP had only a modest
non-significant analgesic effect (25.83 ± 11.37% hat
4 h), a phenomenon which was already seen for naive
animals.
3.3. Respective contributions of GABAAR and GlyR
mediated inhibition on pregnanolone antinociception
One of the surprising results obtained in the first part
of this study was the absence of effect of 3a5bTHP on
thermal heat nociception although 3a5bTHP is a posi-
tive allosteric modulator of the GABAARs like
3a5aTHP. Indeed, 3a5aTHP reduced both mechanicaland thermal nociceptive thresholds and this effect is
likely to be mediated mainly by a potentiating effect
on GABAARs. Because 3a5bTHP has been shown to
have, in addition to its positive GABAARs modulatory
effect, a negative modulatory action on GlyRs, we tried
to better dissect the 3a5bTHP effects on spinal nocicep-
tive circuits by dissociating the glycinergic and GAB-
Aergic contribution on the two sensory modalities, i.e.
mechanical and thermal heat. To do so, we realized
intrathecal coinjections of 3a5bTHP (1 lM) with either
bicuculline (1 lg in 20 ll) or strychnine (20 lg in 20 ll)
in order to observed its effect on a short term allodynia
due to the blockade of spinal GABAARs or GlyRs,
respectively.
Spinal administration of the two antagonists induced
a transient allodynia which is seen as a reduction in the
mechanical threshold from 418.44 ± 1.02 g to
274.31 ± 2.34 g (30 min after i.t. injection) and from
424.60 ± 2.01 g to 283.43 ± 6.82 g (15 min after i.t.
injection) for bicuculline and strychnine, respectively
(n = 8 per group; ANOVA, p < 0.001). Thermal allo-
dynia was also observed at same time points after the
injection. Withdrawal latencies were reduced from
11.63 ± 0.59 s to 7.48 ± 0.29 s and from 11.65 ± 0.37 s
to 8.72 ± 0.32 s for bicuculline and strychnine, respec-
tively (n = 8 per group; ANOVA, p < 0.001).
While measuring mechanical thresholds in allodynic
animals (Fig. 3), 3a5bTHP had a significant analgesic
Fig. 2. Analgesic effects of the progesterone metabolites 3a5aTHP and
3a5bTHP in carrageenan-inflamed rats. Histograms show the mean
changes observed on mechanical (A) or thermal heat thresholds (B) at
4 h after injection of 3a5aTHP and 3a5bTHP. Asterisk indicates
statistical significance (***p < 0.001, n = 6 per group) using ANOVA.
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allodynia (strychnine: 274.31 ± 2.34 g; strych-
nine + 3a5bTHP: 337.19 ± 7.31 g; n = 8; ANOVA,
p < 0.001). This corresponded to an analgesic potency
of 18.96 ± 2.57%. No changes were noted in mechanical
allodynia triggered by spinal bicuculline if 3a5bTHP
was added in the injection solution (Fig. 3A).
While measuring thermal heat thresholds to heat
stimulus, we still found that 3a5bTHP reduced strych-Fig. 3. Effects of 3a5bTHP on strychnine- and bicuculline-induced
allodynia. The histograms illustrate the changes in mean pressure
threshold (A) or latency time (B) if the injection of bicuculline (white
bar) or strychnine (black bar) was realized in the simultaneous
presence of 3a5bTHP (1 lM). Asterisk indicates statistical significance
(***p < 0.001; *p < 0.05; n = 8 per group) using ANOVA.nine allodynia (strychnine: 8.72 ± 0.32 s; strych-
nine + 3a5bTHP: 11.00 ± 0.17 s; n = 8; ANOVA,
p < 0.001) of 26.07 ± 1.93%, but surprisingly, 3a5bTHP
reinforced the allodynia to thermal heat (Fig. 3B)
induced by bicuculline (bicuculline: 7.48 ± 0.29 s; bicu-
culline + 3a5bTHP: 5.96 ± 0.15 s; n = 8). This rein-
forcement of thermal heat allodynia was of 20.37 ±
2.06% and was statistically significant (ANOVA, p <
0.05, Fig. 3B).
4. Discussion
In this study, we characterized the modulatory role of
reduced metabolites of progesterone on spinal nocicep-
tion in healthy animals and in a model of inflammatory
pain. These compounds (3a5aTHP and 3a5bTHP), used
at concentration ranging from 10 nM to 10 lM, are
known to modulate the inhibitory tone mediated by
spinal GABAARs [21,32,38] and GlyRs [19]. We
showed that 3a-reduced neurosteroids (but not 3b),
injected intrathecally at low micromolar concentrations
in the lumbar region of the spinal cord, produced a tran-
sient analgesia in naive and carrageenan-inflamed ani-
mals. 3a5aTHP was analgesic on both mechanical and
thermal heat nociceptive modality. This was not the case
for 3a5bTHP which produced antinociception on
mechanical reflex thresholds but had no apparent effect
on thermal heat. By blocking the fast glycinergic (strych-
nine-induced allodynia) or GABAergic inhibitory con-
trols (bicuculline-induced allodynia), we found that
this analgesic effect was mainly mediated by a potentia-
tion of GABAAR function control in the spinal cord. In
bicuculline-induced allodynia, we also show that 3a5b
significantly decrease threshold to thermal heat thresh-
olds (proalgesia), a result which is in good agreement
with the recently described decrease of GlyR function
[19]. This phenomenon is likely to explain the absence
of apparent analgesia seen with thermal heat nocicep-
tion because 3a5b had opposite effects of GlyR- and
GABAAR-mediated spinal inhibition.
In our study, the beneficial effects of neurosteroids on
pain thresholds in naive and carrageenan-inflamed ani-
mals were mainly seen while using 3a5aTHP, 3a5bTHP
but not 3b5bTHP. This result is in good agreement with
a positive allosteric modulation of the inhibitory cur-
rents mediated by extrasynaptic and synaptic GABA-
ARs seen in various structure of the CNS [16] but also
in the spinal cord [21,29,32,35,36,38]. GABAAR func-
tion was never seen to be modulated by 3b5bTHP
[16,22,31] and this compound, infused at 10 lM, repre-
sents a very important control in order to eliminate pos-
sible non-specific (and non-GABAAR-mediated)
membrane effects resulting in analgesia. So far very
few data are available regarding the use of neurosteroids
to prevent pain symptoms in physiological and patho-
logical situations. In male mice, intracerebroventricular
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dependently increased the pain thresholds to heat stim-
ulus [20], an effect which was mediated by GABAARs
(i.e. bicuculline and picrotoxin sensitive). In this study,
progesterone was less potent than 3a5aTHP and, inter-
estingly, 3a5bTHP was without effect. This is also the
case in our hands but we clearly show that 3a5bTHP
is analgesic for mechanical nociceptive thresholds, a
modality which was not tested in the work of Kavaliers
and Wiebe. Moreover, we obtained a dose-dependent
increase in the mechanical threshold using 3a5aTHP
and 3a5bTHP. The analgesic response for thermal heat,
seen only for 3a5aTHP, was also dose-dependent but
the maximal effect was seen at the lowest concentration
of 3a5aTHP (1 lM). It is interesting to note that such a
difference in the efficacy of progesterone metabolites,
administered at the periphery or centrally, was also
observed while measuring thermal heat nociception
using the tail flick test [9]. At the higher concentration
(10 lM), 3a5aTHP had a lower efficacy to produce anal-
gesia. This has been seen previously while studying the
potentiation of GABAAR function by increasing con-
centrations of 3a-neurosteroids in frog melanotrophs
[22]. A reduction in the amplitude of GABAAR total
current is seen only when they are induced by micromo-
lar concentration of extracellular GABA co-applied
with high concentration of pregnanolone (10 lM).
Using lower concentration of GABA, this negative effect
is never seen. Based on this result, we can speculate that
thermal nociceptive thresholds are placed under a tonic
control realized by GABAARs, a situation rendering
them more sensitive to neurosteroid modulation. This
seems actually to be the case since we showed recently
that endogenous neurosteroids are produced in the dor-
sal horn of the spinal cord in rats exhibiting inflamma-
tory pain symptoms [32]. In this pathological situation,
the local production of neurosteroids reduced thermal
heat hyperalgesia and not mechanical allodynia [32]. It
should be noted here that the local production of neu-
rosteroids is realized in the most superficial layers of
the spinal cord, including lamina II, an area containing
a dense population of GABAergic interneurons and
receiving an important number of thermal sensory
inputs [13,28].
On the other hand, we failed to reveal any effects of
3a5bTHP on thermal heat nociception in naive and car-
rageenan animals. The absence of effect might result
from differences in the efficacy of the two different iso-
mers (5a vs. 5b). In particular, we cannot exclude a loss
of specificity (other membrane protein affected) or a
change in the allosteric modulation of the amino acid
receptor-channels (positive, silent or negative) while
using micromolar concentrations [33,38]. Alternatively
and since 3a5bTHP has the same potency than
3a5aTHP on GABAAR function [19,22], we hypothe-
sized that 3a5bTHP might have a complex effect actingpositively on GABAARs and negatively in GlyRs [19].
The sum of these two opposite modulations might
explain the apparent absence of effect on thermal heat
nociception. To test this hypothesis we used the model
of allodynia triggered by the intrathecal injection of
the GABAAR antagonist bicuculline or the GlyR
antagonist strychnine [18,37]. This allowed us to evalu-
ate how the modulation of GABAARs and GlyRs by
3a5bTHP could contribute to limit thermal heat hyper-
algesia and mechanical allodynia. After blockade of
GlyRs by i.t. injection of strychnine, we found that
3a5bTHP produced an efficient transient reduction of
mechanical allodynia and thermal heat hyperalgesia.
This result illustrates the analgesic contribution of
3a5bTHP through its action on GABAARs. On the
other hand, 3a5bTHP applied after blockade of spinal
GABAARs (bicuculline-induced allodynia) had no
effect on mechanical threshold and, moreover, was pro-
algesic for thermal heat. This fast effect, compatible with
the modulation of a receptor-channel, is likely to be
explained by a negative modulation of spinal GlyR,
although we can not exclude another modulatory action
on a still unidentified receptor [33]. Because 3a5bTHP
may act differentially on GlyRs and GABAARs, we
should keep in mind that these effects might also have
functional consequences on the modulation of locomo-
tor activity or anxiety/depression (not restrictive), two
behaviors which were not evaluated in this study but
received attention previously [10].
In conclusion, this study illustrates the importance of
the modulation of fast inhibitory transmission during
spinal pain processing in physiological and pathological
situations. It brings novel arguments characterizing the
respective roles of GlyR and GABAAR-channels in
the control of pain symptoms triggered by mechanical
or thermal heat stimulus. We show for the time that ste-
reoisomer reduced metabolites of progesterone can be
used to finely modulate the expression of pain symp-
toms. The use of these metabolites, which are devoid
of any genomic effects [33,34], may be of significant
interest in order to develop novel strategies, with syn-
thetic or naturally present neurosteroids, in order to
treat pathological pain symptoms with respect to their
sensory modality.Acknowledgements
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